Calithera Biosciences
South San Francisco
About Calithera Biosciences
Calithera Biosciences is a development-stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. They are applying Their scientific expertise to build a pipeline of unique anti- cancer drugs that selectively target metabolic and apoptotic pathways critical to tumor growth and survival.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $341.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2022)
- Ticker: nasdaq:CALA
- Website: calithera.com
- Phone: +1 650 870 1000
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/calithera-biosciences-131969 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.